Connie Law, PharmD, is a Residency Preceptor with the Pharmacy Residency Program and a Clinical Pharmacy Specialist in Drug Information and Policy Development.
Areas of Expertise:
Anticoagulation, Process Improvement Locations:Main Hospital
Dr. Law is also involved in Anticoagulation Monitoring Program and Drug Use Evaluation committee at CHOP. She completed training in LEAN, SIX SIGMA, and CHOP Improvement Leadership program. She actively participates in various process improvement and cost savings initiatives.
Areas of Interest
LEAN and SIX SIGMA
Education and Training
Pharmacy Practice (PGY1) - The Philadelphia Veterans Affair Medical Center, Philadelphia, PA
Drug Information Specialty (PGY2) - Thomas Jefferson University Hospital, Philadelphia, PA
Doctor of Pharmacy - University of the Sciences in Philadelphia (USIP), Philadelphia, PA
Titles and Academic Titles
Residency Preceptor, Pharmacy Residency Program
Clinical Pharmacy Specialist in Drug Information and Policy Development
Statin therapy in HCV Non-formulary medication management
Law C, Raffini. A guide to the use of anticoagulant drugs in children. Paediatr Drugs. 2015;17(2):105-14.
Greene LA, Law C, Jung M, Walton S, Ignjatovic V, Monagle P, Raffini LJ. Lack of anti-factor Xa assay standardization results in significant low molecular weight heparin (enoxaparin) dose variation in neonates and children. J Thromb Haemost 2014;12(9):1554-7.
McIntyre C, Law C, Erush S. Drug information skills: An abandoned necessity? AJHP 2014;71(11):900-1.
Posters and Presentations
Bustin, A, Gomes J, Law C. Drug use evaluation of anakinra in a pediatric population. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Ciaramitaro J, Gomes J, Law C. Therapeutic substitution at a pediatric institution: an evaluation. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Hoffman M, Gomes J, Law C. Safety and formulary compliance with parenteral hydantoin anticonvulsant agents in pediatric patients. Poster presented at the 50th (2015) ASHP Midyear Clinical Meeting & Exhibition, New Orleans, LA.
Greene LA, Law C, Jung M, Walton S, Raffini LJ. Lack of Anti-Xa Assay Standardization Results in Significant Dose Variation in Neonates and Children Receiving Enoxaparin. Poster presented at the 55th (2013) American Society of Hematology Annual Meeting and Exposition, New Orleans, LA.
Hummel K, Law C, Le KM, Erush SC. Standardizing the necessity for off-label informed consent: A pediatric undertaking. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Gembarski J, Law C. Dexmedetomidine use in a pediatric population. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Isaacs L, Law C. Safety of the use of isoflurane in the pediatric intensive care unit. Poster presented at the 47th (2012) ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV.
Ravi S, Law C. Review of Sedation Medication-Related Respiratory Adverse Drug Events at a Pediatric Institution. Poster presented at the 46th (2011) ASHP Midyear Clinical Meeting & Exhibition, Anaheim, CA.
Leadership and Memberships
Memberships in professional organizations
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacists (ASHP)
Mid-Atlantic College of Clinical Pharmacy (MACCP)
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.